He looks to you to FOCUS ON RISK REDUCTION for MI, stroke, and coronary revascularization in adult patients with ASCVD
Prevention of cardiovascular events: Repatha® is indicated as an adjunct to diet and standard of care therapy (including moderate- to high-intensity statin therapy alone or in combination with other lipid-lowering therapy), to reduce the risk of myocardial infarction, stroke, and coronary revascularization in adult patients with atherosclerotic cardiovascular disease (ASCVD) by further lowering low-density lipoprotein cholesterol (LDL-C) levels.1
* Fictitious patient. May not be representative of all patients.
ASCVD=atherosclerotic cardiovascular disease; CV=cardiovascular; MI=myocardial infarction